DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,582,000 | -53.8% | 128,068 | -14.4% | 0.00% | -50.0% |
Q2 2021 | $5,587,000 | +207.8% | 149,686 | +110.8% | 0.00% | +100.0% |
Q1 2021 | $1,815,000 | +184.0% | 70,992 | +144.6% | 0.00% | – |
Q4 2020 | $639,000 | -90.1% | 29,018 | -91.9% | 0.00% | -100.0% |
Q3 2020 | $6,478,000 | +216.3% | 360,090 | +346.7% | 0.00% | +300.0% |
Q2 2020 | $2,048,000 | +21.7% | 80,612 | -12.1% | 0.00% | -50.0% |
Q1 2020 | $1,683,000 | +216.4% | 91,662 | +279.9% | 0.00% | +100.0% |
Q4 2019 | $532,000 | +247.7% | 24,127 | +131.7% | 0.00% | – |
Q1 2019 | $153,000 | +12.5% | 10,412 | -27.0% | 0.00% | – |
Q1 2018 | $136,000 | +338.7% | 14,262 | +38.8% | 0.00% | – |
Q2 2016 | $31,000 | – | 10,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,930,237 | $85,373,000 | 50.34% |
RTW INVESTMENTS, LP | 5,029,462 | $48,082,000 | 4.58% |
EcoR1 Capital, LLC | 4,764,447 | $45,548,000 | 4.57% |
RA Capital Management | 3,933,489 | $37,604,000 | 2.88% |
Cormorant Asset Management, LP | 3,600,954 | $34,425,000 | 2.57% |
Omega Fund Management, LLC | 223,457 | $2,136,000 | 2.10% |
Ghost Tree Capital, LLC | 950,000 | $9,082,000 | 1.84% |
EMORY UNIVERSITY | 246,411 | $2,356,000 | 1.68% |
Trustees of Princeton University | 114,286 | $1,093,000 | 1.63% |
BRIDGER MANAGEMENT, LLC | 1,226,820 | $11,728,000 | 0.71% |